Start here if you're new
what it is
J&J Snack Foods makes frozen drinks, snack foods, and treats sold in arenas, schools, stores, and foodservice counters.
how it gets paid
Last year J&J Snack Foods made $1.6B in revenue. Frozen beverages was the main engine at $0.56B, or 35% of sales.
why it's growing
Revenue grew 0.5% last year. Revenue came in at $344M, and EPS was $0.05.
what just happened
J&J Snack Foods posted a $344M quarter as sales fell 5% and EPS landed at 5 cents.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
30/100 earnings predictability — expect surprises
21.2x trailing p/e — priced about right
3.6% dividend yield — cash in your pocket every quarter
9.5% return on capital — nothing to write home about
xvary composite: 50/100 — below average
What they do
J&J Snack Foods makes frozen drinks, snack foods, and treats sold in arenas, schools, stores, and foodservice counters.
J&J sells through 5 channels: stadiums, schools, movie theaters, club stores, and foodservice counters. That is 5 ways to reach customers, not 1. switching suppliers -> changing equipment, menus, and habits -> your local snack stand does not swap overnight. operating margin -> core profit before interest and tax -> 13.5% means every $100 of sales kept $13.50.
How they make money
$1.6B
annual revenue · their business grew +0.5% last year
Frozen beverages
$0.56B
+0.0%
Snack foods
$0.48B
+0.0%
Specialty snack retail outlets
$0.24B
1.0%
Frozen novelties
$0.19B
+1.0%
Foodservice and club-store distribution
$0.13B
+0.0%
The products that matter
manufactures and sells branded snacks
Branded Snack Foods
$1.6B revenue
it's the whole $1.6B business. That simplicity helps you follow it. It also means there's nowhere to hide when demand softens.
entire business
frozen beverages and concession channels
ICEE and foodservice mix
$343.8M latest quarter
the latest quarter fell 5.2% to $343.8M. Management blamed a tough comparison against last year's movie-driven beverage demand and weaker customer traffic. In human-speak: volumes were softer.
demand watch
pricing, plant changes, and operating cleanup
Transformation efforts
$24M plant-closure charges
management is cutting costs and reshaping operations, but $24M in plant-closure costs tells you the cleanup is still happening in public. Savings matter later. Charges hit now.
execution risk
Key numbers
$1.6B
annual revenue
You are looking at a $1.6B business with projected sales growth of 1.0%. Big base, tiny lift.
13.5%
operating margin
Operating margin means core profit before interest and tax. At 13.5%, every $100 of sales kept $13.50.
3.6%
dividend yield
The payout pays you while you wait. A 3.6% yield beats cash, but it does not fix weak sales.
9.5%
return on capital
Return on capital means profit produced from money invested in the business. At 9.5%, the company is decent, not flashy.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- net profit margin 5.9% — keeps 6 cents of every dollar in revenue
- return on equity 10% — $0.10 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in JJSF 3 years ago → it's now worth $6,370.
The index would have given you $13,920.
source: institutional data · total return
What just happened
missed estimates
J&J Snack Foods posted a $344M quarter as sales fell 5% and EPS landed at 5 cents.
Revenue came in at $344M, and EPS was $0.05. Gross margin improved to 27.9% from 25.9%, so cost control helped, but demand still lagged.
$344M
revenue
$0.05
eps
27.9%
gross margin
the number that mattered
Revenue was $344M, down 5%, and that says the business is leaning on margin work instead of volume.
-
j&j snack foods business performance was mixed in fiscal 2025 (ended september 30, 2025).
-
fourth-quarter sales dipped 4% from the prior-year period as the company lapped strong frozen beverage unit volumes tied to a major movie release last year and faced demand weakness.moreover, the softer consumer environment over the past year had placed some pressure on volumes, as shoppers and foodservice customers have become more price sensitive. in addition, elevated ingredient costs (namely cocoa) and tariff headwinds have compressed margins in the early part of the year. although the company implemented upward price adjustments, benefits from these actions phased out by the fiscal fourth quarter.
-
further, cost-cutting actions have been put in place (more below) in order to improve operations.note: year-to-year comparisons are not meaningful as we have adjusted our fiscal 2025 figures to exclude nonrecurring items, such as $24 million in plant closures in the fiscal fourth quarter.
-
on an apples-to-apples basis, adjusted share earnings of $1.58 notched two pennies lower than the year-ago period, reflecting resilient operating performance despite top-line weakness.
-
the company is focused on a business transformation strategy.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
JJSF's problem is specific: sales just fell 5.2% to $343.8M while the business only keeps 5.7% of revenue as profit. When demand softens in a low-margin snack business, the math gets mean quickly.
high
volume weakness in foodservice and frozen beverages
latest-quarter sales fell 5.2% to $343.8M, with management citing softer demand and a difficult comparison against last year's movie-driven ICEE volumes.
if volume stays soft, profit pressure compounds fast because the company only runs at a 5.7% net margin.
med
cocoa, ingredient, and tariff pressure
management flagged elevated cocoa costs and tariff pressure earlier in the year, and the benefit from price increases had largely phased out by the fiscal fourth quarter.
that matters because when you keep about 6 cents on each $1 of revenue, input cost pressure does not need to be dramatic to hurt earnings.
med
transformation execution risk
the company is pushing a business transformation strategy, and fiscal fourth-quarter results included $24M in plant-closure costs.
if the charges keep showing up without cleaner margins, you get the cost of change without the benefit of change.
low
estimate reliability
earnings predictability is only 30/100, and quarterly EPS swung from $0.33 to $2.00 during FY2025.
that makes the $4.50 FY2026 EPS estimate useful as a guide, not something you should mistake for a promise.
the kill criterion is simple: if sales keep falling and margin does not improve from 5.7%, this stays a recovery pitch instead of a recovery.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
quarterly sales after the $343.8M print
one more quarter of shrinking revenue would make the temporary-blip case much harder to defend.
risk
cocoa and tariff pressure
with only a 5.7% net margin, you want to see input costs easing or pricing holding better. There is not much buffer here.
trend
FY2026 EPS estimate at $4.50
if that estimate starts moving down, the stock gets less cheap than the 21.2x trailing multiple makes it look.
calendar
next earnings report and margin commentary
the next report needs to show whether cost cuts are turning into cleaner results or just extending the transition story.
Analyst rankings
short-term outlook
below average
momentum score 4. in human-speak, analysts think this stock needs better evidence before it earns a stronger near-term setup.
risk profile
average
stability score 3. you're not looking at a collapse candidate, but this is not a bunker stock either.
chart momentum
below average
technical score 4. The chart still looks like a stock in repair mode.
earnings predictability
30 / 100
earnings can surprise in both directions. That matters more when the business is already fighting for volume.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 132 buyers vs. 108 sellers in 3q2025. total institutional holdings: 15.4M shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$79
$160
$91
current price
$120
target midpoint · +32% from current · 3-5yr high: $165 (+80% · 16% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive